Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

Strahlentherapie und Onkologie

Volumn 184, Issue 9, 2008, Pages 457-464

  Vliegen, Roy F A ^a,b   Beets Tan, Regina G ^a   Vanhauten, Bart ^a   Driessen, Ann ^a   Oellers, Michel ^a   Kessels, Alfons G ^a   Arens, Ann ^a   Beets, Geerard L ^a   Buijsen, Jeroen ^a   Van Baardwijk, Angela ^a   De Ruysscher, Dirk ^a   Lammering, Guido ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

Author keywords

Chemoradiation; PET CT; Rectal cancer; Total mesorectal excision; Tumor response evaluation

Indexed keywords

CAPECITABINE; FLUORODEOXYGLUCOSE F 18; IODINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; FASCIA; FEMALE; HUMAN; MALE; MESORECTAL FASCIA; POSITRON EMISSION TOMOGRAPHY; RECTUM CANCER; TUMOR REGRESSION; TUMOR VOLUME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FASCIA; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RECTAL NEOPLASMS; RECTUM; SOFTWARE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56549130778     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1858-7     Document Type: Article

References (41)

1. Amthauer H, Denecke T, Rau B, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004;31:811-9.
2. Bagatzounis A, Koelbl O, Oppitz U. Das lokoregionäre Rezidiv des Rektumkarzinoms: eine computertomographische Analyse und ein Zielvolumenkonzept für die adjuvante Radiotherapie. Strahlenther Onkol 2006;173: 68-75.
3. Beets-Tan RG, Beets GL,Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357:497-504.
4. Bonnen M, Crane C, Vauthey J, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 cancer patients. Int J Radiat Oncol Biol Phys 2004;60:1098-105.
5. Calvo FA, Domper M, Matute R, et al. F-FDG positron emission tomography and restaging in rectal cancer terated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528-35.
6. Capirci C, Rampin L, Erba P, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583-93.
7. Capirci C, Rubello D, Chierichetti F, et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother 2004;58:451-7.
8. Cascani GL, Avallone A, Delrio P, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006;47:1241-8.
9. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668-74.
10. Chen C, Lee R, Lin J, et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2004;48:722-8.
11. Ciernik IF, Huser M, Burger C, et al. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:893-900.
12. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;233:93-100.
13. Daisne JF, Sibomana M, Bol A, et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 2003;69:247-50.
14. Denecke T, Rau B, Hoffmann KT, et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 2005;15:1658-66.
15. Govindarajan A, Coburn N, Kiss A, et al. Population based assessment of the surgical management of locally advanced rectal cancer. J Natl Cancer Inst 2006;98:1474-81.
16. Grosu AL, Piert M, Weber WA, et al. Position emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:65-76.
17. Guillem JG, Puig-La Calle J, Akhurst T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluordeoxyglucose positron emission tomography. Dis Colon Rectum 2000;43:18-24.
18. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumours receiving radiotherapy. J Nucl Med 1991;32:1485-90.
19. Habr-Gama A, Perez R, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240:711-7.
20. Haustermans K, Roels S, Verstraete J, et al. Adaptive RT in rectal cancer: superior to 3D-CRT? A simple question, a complex answer. Strahlenther Onkol 2007;183:Suppl 2:21-3.
21. Hoffmann K, Rau B, Wust P, et al. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radiochemotherapy plus regional hyperthermia. Coloproctology 2002;24:253-61.
22. Kuo L, Chern M, Tsou M, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005;48:23-8.
23. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005;26:259-68.
24. Lehnert T, Methner M, Pollok A, et al. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002;235:217-25.
25. Luna-Perez P, Bustos-Cholico E, Alvarado I, et al. Prognostic significance of the circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2005;90:20-5.
26. MacFarlane J, Ryall R, Heald R. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
27. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 1994;73:2680-6.
28. Melton G, Lavely W, Jacene H, et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 2007;11:961-9.
29. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333:779-90.
30. Nagtegaal I, Marijnen C, Kranenbarg E, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-7.
31. Oellers M, Bosmans G, van Baardwijk A, et al. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning. Radiother Oncol 2008;87:142-6.
32. Palmer G, Martling A, Blomqvist L, et al. Outcome after the introduction of a multimodality treatment program for locally advanced rectal cancer. Eur J Surg Oncol 2005;31:727.
33. Paulsen F, Scheiderbauer J, Eschmann SM, et al. First experiences of radiation treatment planning with PET/CT. Strahlenther Onkol 2006;182:369-75.
34. Quirke P, Dixon M. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3:127-31.
35. Rhomberg W, Hammer J, Sedlmayer F, et al. Irradiation with and without razoxane in the treatment of incomplete resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study. Strahlenther Onkol 2007;183:380-4.
36. Rodel C, Sauer R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 2007;183:227-35.
37. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Eng J Med 2004;351:1731-40.
38. Schiepers C, Haustermans K, Geboes K, et al. The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma. Cancer 1999;85:803-11.
39. Van Baardwijk A, Bosmans G, Boersma L, et al. PET-CT-based auto-contouration in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007;68:771-8.
40. Van Ginkel RJ, Hoekstra HJ, Pruim J, et al. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced sift tissue sarcoma. J Nucl Med 1996;37:984-90.
41. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer 1999;35:1773-82.